Skip to content

Assessment of the Hemodynamic Effects of PEEP According to Alveolar Recruitment During the ARDS

Assessment of the Hemodynamic Effects of PEEP According to Alveolar Recruitment During the ARDS

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05524558
Enrollment
34
Registered
2022-09-01
Start date
2022-02-01
Completion date
2022-11-30
Last updated
2022-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Human, Ventilation Therapy; Complications, Alveolar; Disorder

Brief summary

The corner stone of the treatment of ARDS is mechanical ventilation with high levels of positive end-expiratory pressure, also called PEEP. A high level of PEEP is recommended and frequently used. But PEEP can lower cardiac output and contribute to circulatory failure during mechanical ventilation. Nevertheless, in theory, the PEEP-induced pulmonary vascular resistance (PVR) increase could depend on the level of alveolar recruitment, but it has never been proven. Thus, the aim of this study is to determine the relation between the high-PEEP induced PVR and the alveolar recruitment or overdistension.

Detailed description

During acute respiratory distress syndrome (ARDS) the application of positive end-expiratory pressure (PEEP) prevents expiratory alveolar collapse. However, it can induce a predominant recruitment effect or, on the contrary, alveolar overdistension. The recruitment/overdistension ratio can be easily assessed using R/I ratio (or recruitment-to-inflation ratio). However, PEEP is likely to lower cardiac output and contribute to the cardiovascular failure that often occurs in patients with ARDS. Among its hemodynamic effects, PEEP is likely to increase pulmonary vascular resistance and, thus, right ventricular afterload. In theory, this effect should only occur if PEEP over-distends the lung volume, compressing the extra-alveolar vessels and increasing their resistance. However, this different effect of PEEP on pulmonary vascular resistance depending on the degree of recruitment or overdistension has never been demonstrated during ARDS in humans. We retrospectively studied data collected from patients with ARDS, monitored by pulmonary artery catheter (PAC), to eventually find a correlation between the high PEEP-induced PVR increase and recruitement/overdistension profile.

Interventions

PAC already in place

DEVICEEsophagal pressure

Esophagal pressure already in place

Sponsors

Bicetre Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* ARDS diagnosed * Invasive mechanical ventilation * Pulmonary artery catheter already in place * Esophagal pressure measure

Exclusion criteria

* Pregnancy * Prone position at inclusion * Legal protection measures

Design outcomes

Primary

MeasureTime frameDescription
Correlation between PVR and recruitment-to-inflation ratioUp to hospital discharge (maximum : day 60)PVR collected at two levels of PEEP and the R/I ratio to assess a relationship between the two variables

Secondary

MeasureTime frameDescription
Relationship between the R/I ratio and blood gas analysisUp to hospital discharge (maximum : day 60)Data collected from the daily blood samples, to assess a relationship between R/I and arterial oxygen pressure
Relationship between the R/I ratio and respiratory system complianceUp to hospital discharge (maximum : day 60)Ventilatory parameters collected at two levels of PEEP and R/I collected every day to assess a correlation between R/I and lung compliance
Relationship between right ventricle size and R/I ratioUp to hospital discharge (maximum : day 60)Echocardiographic data collected at two levels of PEEP and R/I collected every day to assess a relationship between R/I and changes in RV surface.
Relationship between PVR change and Transpulmonary gradient (TPG) according to R/IUp to hospital discharge (maximum : day 60)Data collected from PAC and R/I measure every day to assess the relationship between R/I and TPG at two levels of PEEP.

Countries

France

Contacts

Primary ContactXavier Monnet, Pr
xavier.monnet@aphp.fr01 45 21 35 39

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026